The research compound serious buyers are talking about — and what the science actually says.
The peptide and research compound space moves fast. In 2026, one molecule keeps appearing in the same conversations as BPC-157, NAD+ precursors, and GLP-1 research: 5-Amino-1MQ.
It is not a peptide. It is not a stimulant. It is a small-molecule NNMT inhibitor — and if you understand what that means, you already know why it matters.
What Is NNMT — and Why Should You Care?
Nicotinamide N-methyltransferase (NNMT) is an enzyme expressed primarily in adipose (fat) tissue. Its job is to methylate nicotinamide — but elevated NNMT activity has been linked in peer-reviewed research to impaired metabolic function, reduced NAD+ availability, and disrupted energy regulation at the cellular level.
In plain terms: high NNMT activity is associated with metabolic dysfunction. Inhibiting it is an active area of scientific investigation.
What Does 5-Amino-1MQ Actually Do?
5-Amino-1MQ is a selective, cell-permeable NNMT inhibitor. Unlike broad-spectrum metabolic compounds, it targets NNMT specifically — crossing the cell membrane to act at the enzymatic level without the off-target effects that make older compounds difficult to study cleanly.
Research interest centres on its potential to:
- Restore NAD+ and SAM (S-adenosylmethionine) availability
- Influence how cells handle energy substrate utilisation
- Support metabolic pathway regulation at the mitochondrial level
This is not a fat burner. It does not suppress appetite. It works upstream — at the enzyme.
How Does It Compare to Other Research Compounds?
In 2026, the most-searched research compounds in the UK include BPC-157, TB-500, Semaglutide analogues, NAD+ precursors (NMN, NR), and NNMT inhibitors like 5-Amino-1MQ. What separates 5-Amino-1MQ from the peptide category is its oral bioavailability — no reconstitution, no injection, no cold storage. One capsule. Done.
For researchers comparing sourcing options, that matters.
The Sourcing Problem — and Why It Matters
The research compound market has a quality problem. Underdosed capsules, unlabelled fillers, overseas shipping delays, and grey-market suppliers with no accountability. It is a real issue that compromises research integrity.
At True Ability Labs, we supply one compound. We dose it accurately. We test it. What is on the label is what is in the capsule — 50mg of 5-Amino-1MQ, nothing else.
What You Receive
- 5-Amino-1MQ — 50mg per capsule, accurately dosed
- 60 capsules — a 60-day supply at one capsule per day
- Clean HPMC vegan capsules — no fillers, no binders, no guesswork
- UK dispatch — same day before 1PM, Monday to Friday
- Discreet, secure packaging — every order
Who This Is For
Informed adults conducting personal research. Biohackers who read the studies. Buyers who are tired of underdosed products from unaccountable suppliers.
Not for under-18s, pregnant or breastfeeding individuals, or anyone on medication without prior medical advice.
The Bottom Line
5-Amino-1MQ is one of the most scientifically interesting NNMT inhibitors available to UK researchers in 2026. The compound is legal, the research is growing, and the sourcing question has one clear answer.
Food supplement. Not a medicine. Not intended to diagnose, treat, cure, or prevent any disease. For research purposes.
